O'Brien M - Search Results

1

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR; KEYNOTE-024 Investigators. Reck M, et al. N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8. N Engl J Med. 2016. PMID: 27718847 Free article. Clinical Trial.

2

The role of chemotherapy for metastatic gastric cancer.

O'Brien ME, Cunningham D. O'Brien ME, et al. J Infus Chemother. 1995 Summer;5(3):112-6. J Infus Chemother. 1995. PMID: 8528967 Review.

3

Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors.

Hickish TF, Smith IE, O'Brien ME, Ashley S, Middleton G. Hickish TF, et al. Br J Cancer. 1998 Jul;78(1):28-33. doi: 10.1038/bjc.1998.437. Br J Cancer. 1998. PMID: 9662246 Free PMC article.

4

A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.

Hickish TF, Smith IE, Nicolson MC, Ashley S, Priest K, Spencer L, Norman A, Middleton G, O'Brien ME. Hickish TF, et al. Br J Cancer. 1998 Jun;77(11):1966-70. doi: 10.1038/bjc.1998.326. Br J Cancer. 1998. PMID: 9667676 Free PMC article.

5

Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.

de Boer RH, Smith IE, Pastorino U, O'Brien ME, Ramage F, Ashley S, Goldstraw P. de Boer RH, et al. Br J Cancer. 1999 Mar;79(9-10):1514-8. doi: 10.1038/sj.bjc.6690241. Br J Cancer. 1999. PMID: 10188899 Free PMC article. Clinical Trial.

6

A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.

O'Brien ME, Saini A, Smith IE, Webb A, Gregory K, Mendes R, Ryan C, Priest K, Bromelow KV, Palmer RD, Tuckwell N, Kennard DA, Souberbielle BE. O'Brien ME, et al. Br J Cancer. 2000 Oct;83(7):853-7. doi: 10.1054/bjoc.2000.1401. Br J Cancer. 2000. PMID: 10970684 Free PMC article. Clinical Trial.

7

Serum p53 antibodies: predictors of survival in small-cell lung cancer?

Murray PV, Soussi T, O'Brien ME, Smith IE, Brossault S, Norton A, Ashley S, Tavassoli M. Murray PV, et al. Br J Cancer. 2000 Dec;83(11):1418-24. doi: 10.1054/bjoc.2000.1475. Br J Cancer. 2000. PMID: 11076647 Free PMC article.

8

Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin.

Smith IE, O'Brien ME, Talbot DC, Nicolson MC, Mansi JL, Hickish TF, Norton A, Ashley S. Smith IE, et al. J Clin Oncol. 2001 Mar 1;19(5):1336-43. doi: 10.1200/JCO.2001.19.5.1336. J Clin Oncol. 2001. PMID: 11230476 Clinical Trial.

9

Mitomycin C, vinblastine and carboplatin: effective outpatient chemotherapy for advanced non-small cell carcinoma of the lung (NSCLC).

Gregory RK, Smith IE, Norton A, Ashley S, O'Brien ME. Gregory RK, et al. Clin Oncol (R Coll Radiol). 2001;13(6):483-7. doi: 10.1053/clon.2001.9320. Clin Oncol (R Coll Radiol). 2001. PMID: 11824893

10

A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy.

Assersohn L, Souberbielle BE, O'Brien ME, Archer CD, Mendes R, Bass R, Bromelow KV, Palmer RD, Bouilloux E, Kennard DA, Smith IE. Assersohn L, et al. Clin Oncol (R Coll Radiol). 2002 Feb;14(1):23-7. doi: 10.1053/clon.2001.0030. Clin Oncol (R Coll Radiol). 2002. PMID: 11899903 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,317 results

Search Page